Favipiravir

Showing of 1 - 20 from 22 results
Favipiravir - Total results - 22
Favipiravir at high doses works to curb COVID-19 in hamsters, HCQ ineffective: Study
science

Favipiravir at high doses works to curb COVID-19 in hamsters, HCQ ineffective: Study

Researchers warned that 'Favipiravir is not a panacea', since it wasn't specifically developed for coronaviruses.

Coronavirus Updates: Maharashtra reports 14,492 new COVID-19 cases, 326 deaths; tally rises to 6,43,289
India

Coronavirus Updates: Maharashtra reports 14,492 new COVID-19 cases, 326 deaths; tally rises to 6,43,289

Coronavirus LIVE Updates: As many as 26 volunteers who reached the Air-India Express plane crash site in Kozhikode evacuated the injured passengers on 7 August, have tested positive for COVID-19

Coronavirus Updates: 11,514 new COVID-19 cases in Maharashtra today; tally rises to 4,79,779
India

Coronavirus Updates: 11,514 new COVID-19 cases in Maharashtra today; tally rises to 4,79,779

Coronavirus LIVE Updates: The Maharashtra health department said that 11,514 COVID-19 cases and 316 deaths were reported in the state on Thursday. Total number of cases in the state is now at 4,79,779, including 1,46,305 active cases, 3,16,375 recovered and 16,792 deaths.

Zenara Pharma gets DCGI approval to sell Favipiravir tablet Favizen to treat mild to moderate COVID-19 infections
science

Zenara Pharma gets DCGI approval to sell Favipiravir tablet Favizen to treat mild to moderate COVID-19 infections

The company is in talks with various institutions to make the tablets available at discounted or no cost to underprivileged patients.

Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection
science

Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection

The Covihalt tablet will be available in 200 mg tablets in a strip of 10 and will cost Rs 49 per tablet in India.

Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill
science

Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill

Favipiravir is an antiviral drug that was originally made to treat influenza in Japan under the brand name Avigan.

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients
India

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

Favipiravir is an antiviral drug which was developed by a Japanese pharma company, Fujifilm Toyama Chemical, to treat influenza.

Coronavirus Outbreak Updates: Madhya Pradesh govt to promote 1st, 2nd year UG students based on previous scores; 1,128 cases in Mumbai today
India

Coronavirus Outbreak Updates: Madhya Pradesh govt to promote 1st, 2nd year UG students based on previous scores; 1,128 cases in Mumbai today

Coronavirus Outbreak LIVE Updates: Tamil Nadu reported 2,710 new COVID-19 cases and 37 deaths, taking the total number of cases to 62,087 and death toll to 794. Number of active cases stands at 27,178.

Favipiravir is now the first oral COVID-19 treatment approved in India: All you need to know
science

Favipiravir is now the first oral COVID-19 treatment approved in India: All you need to know

Glenmark claims that favipiravir showed improvement of up to 88 percent in mild to moderate COVID-19 cases.

Coronavirus Outbreak Updates: Confirmed cases in Mumbai surge to 66,507 as city reports 1,242 new infections; toll rises to 3,669 with 41 deaths
India

Coronavirus Outbreak Updates: Confirmed cases in Mumbai surge to 66,507 as city reports 1,242 new infections; toll rises to 3,669 with 41 deaths

Coronavirus Outbreak Updates: Mumbai on Sunday recorded 1,242 new coronavirus positive cases and 41 deaths, taking the total positive cases to 66,507 and toll to 3,669.

Hetero gets DCGI nod to launch anti-viral drug Remdesivir under brand name Covifor for COVID-19 treatment
India

Hetero gets DCGI nod to launch anti-viral drug Remdesivir under brand name Covifor for COVID-19 treatment

The drug has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children, hospitalised with severe symptoms of the disease, the company said.

Indian regulators give Glenmark approval to manufacture, sell favipiravir for ‘restricted emergency use’ in treating COVID-19 patients
India

Indian regulators give Glenmark approval to manufacture, sell favipiravir for ‘restricted emergency use’ in treating COVID-19 patients

Glenmark Pharmaceuticals Ltd has received Indian regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to-moderate COVID-19 infections in the country

COVID-19 pandemic may intensify resistance to antibiotics: Here's what can be done to cope with it
India

COVID-19 pandemic may intensify resistance to antibiotics: Here's what can be done to cope with it

As there is no specific treatment for COVID-19, antibiotics are being used inappropriately to treat symptoms in people confirmed or suspected with COVID-19, increasing the chance of them developing resistant to the antimicrobial treatments

Japanese government gives up on gaining approval for Avigan after study show no evidence of efficacy in COVID-19
World

Japanese government gives up on gaining approval for Avigan after study show no evidence of efficacy in COVID-19

Concerns remain about Avigan, known generically as favipiravir, as it has been shown to cause birth defects in animal studies.

Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients
Business

Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients

On 1 May, Glenmark Pharmaceuticals said it has become the first company in India to receive approval from Drug Controller General of India (DCGI) to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.

Clinical trials are showing that Remdesivir can be life-saving drug for COVID-19 infected patients
science

Clinical trials are showing that Remdesivir can be life-saving drug for COVID-19 infected patients

Remdesivir mimics the genetic material of the coronavirus and prevents new virus copies from being produced.

Strides Pharma receives regulatory approval to conduct trials in India for potential COVID-19 drug
Business

Strides Pharma receives regulatory approval to conduct trials in India for potential COVID-19 drug

Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19

Clinical trials for potential Coronavirus drug — Favipiravir, in Russia, have shown some promising results
World

Clinical trials for potential Coronavirus drug — Favipiravir, in Russia, have shown some promising results

Avigan, known generically as favipiravir, was developed in the late 1990s and works by short-circuiting the reproduction mechanism of RNA viruses.

Glenmark begins Phase 3 trials of antiviral drug Favipiravir to check efficacy on COVID-19 patients in India
science

Glenmark begins Phase 3 trials of antiviral drug Favipiravir to check efficacy on COVID-19 patients in India

Clinical trials are estimated to be completed by July-August and over 10 government and private hospitals are enrolled for the study.

Everything you need to know about Favipiravir, the potential drug for COVID-19 treatment
Health

Everything you need to know about Favipiravir, the potential drug for COVID-19 treatment

Favipiravir is a broad-spectrum antiviral drug that was originally made to treat the flu in Japan.